Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention is important for limited systemic sclerosis patients due to higher pain and ulceration risks.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Severe allergic reactions to hair dye can trigger hair loss and may be linked to multiple sclerosis.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Teriflunomide can cause hair thinning.

MS patients often have skin issues, so regular skin checks are important.

4-aminopyridine helps heal burn wounds faster by reducing inflammation and promoting new blood vessel growth.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Skin issues are common in people with neurodegenerative diseases.

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

Adipose-derived stem cells are promising for tissue and organ repair due to their easy access and versatility.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

Common gene patterns may cause skin autoimmune diseases.

Botulinum toxin, once seen as a poison, is now used to treat medical conditions and is unlikely to be an effective biological weapon.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Calancardin B may help reduce inflammation in immune cells.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

4-Aminopyridine gel speeds up burn wound healing and improves skin regeneration.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

CBD is effective for certain epilepsy conditions, shows promise for other health issues, but needs more research for safety and effectiveness.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

4-aminopyridine helps skin wounds heal faster and better.

The document covers various dermatological conditions and their studies.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.